Kevin Fischbeck
Stock Analyst at B of A Securities
(3.99)
# 583
Out of 5,090 analysts
188
Total ratings
65.15%
Success rate
5.71%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $15.47 | -15.97% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $8.79 | +13.77% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $257.85 | +16.35% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $330.75 | +11.87% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $330.91 | +17.86% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $16.26 | +10.70% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $117.39 | +19.26% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $210.00 | +7.14% | 7 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $112.50 | +42.22% | 2 | Sep 10, 2025 | |
| CNC Centene | Downgrades: Underperform | $52 → $30 | $38.34 | -21.75% | 13 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $231.08 | -19.94% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $486.70 | -15.76% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $0.65 | +359.98% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $151.86 | +189.08% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.42 | -31.00% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $19.55 | -62.92% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $265.44 | +31.86% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $17.19 | +161.78% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.57 | +54.06% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $14.91 | +134.74% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.58 | +287.60% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $8.00 | -6.25% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $29.89 | -39.78% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $22.12 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $30.39 | -37.48% | 2 | Feb 9, 2018 |
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $15.47
Upside: -15.97%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $8.79
Upside: +13.77%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $257.85
Upside: +16.35%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $330.75
Upside: +11.87%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $330.91
Upside: +17.86%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $16.26
Upside: +10.70%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $117.39
Upside: +19.26%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $210.00
Upside: +7.14%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $112.50
Upside: +42.22%
Centene
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $38.34
Upside: -21.75%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $231.08
Upside: -19.94%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $486.70
Upside: -15.76%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $0.65
Upside: +359.98%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $151.86
Upside: +189.08%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.42
Upside: -31.00%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $19.55
Upside: -62.92%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $265.44
Upside: +31.86%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $17.19
Upside: +161.78%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.57
Upside: +54.06%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $14.91
Upside: +134.74%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.58
Upside: +287.60%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $8.00
Upside: -6.25%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $29.89
Upside: -39.78%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $22.12
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $30.39
Upside: -37.48%